695 filings
424B3
ZVRA
Zevra Therapeutics Inc
10 Apr 24
Prospectus supplement
4:23pm
8-K
ZVRA
Zevra Therapeutics Inc
10 Apr 24
Entry into a Material Definitive Agreement
7:46am
EFFECT
ZVRA
Zevra Therapeutics Inc
9 Apr 24
Notice of effectiveness
12:15am
S-3/A
ZVRA
Zevra Therapeutics Inc
Shelf registration (amended)
5 Apr 24
7:39pm
DEFA14A
ZVRA
Zevra Therapeutics Inc
3 Apr 24
Additional proxy soliciting materials
4:17pm
8-K
8zl7ii08w0
28 Mar 24
Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
4:35pm
8-K
gv4r6
26 Mar 24
Zevra Therapeutics Announces Top-Line Data from the Phase 2 Clinical Trial of
8:28pm
8-K
25xepj5u
5 Mar 24
Regulation FD Disclosure
7:34am
8-K
i5q3z0
4 Mar 24
Zevra Therapeutics Provides FDA Update on the PDUFA Action Date for Arimoclomol as a Treatment for Niemann-Pick Disease Type C
8:24am
8-K
3icpl354z 1mrhonrv
28 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:29pm
SC 13G
r6um498uio2n3
14 Feb 24
ZEVRA THERAPEUTICS / Nantahala Capital Management ownership change
4:51pm
8-K/A
0no08ucib3szo8f
5 Feb 24
Financial Statements and Exhibits
12:00am
4
gzl68g
2 Feb 24
ZEVRA THERAPEUTICS / Joshua Schafer ownership change
9:22pm
4
p9mg23
2 Feb 24
ZEVRA THERAPEUTICS / Timothy J. Sangiovanni ownership change
8:17pm
4
aiycg
2 Feb 24
ZEVRA THERAPEUTICS / Christal M M Mickle ownership change
8:14pm
4
0tk1v34zviyd8exx33w
2 Feb 24
ZEVRA THERAPEUTICS / Sven Guenther ownership change
8:13pm
4
c5fkv4l9q6xp8wnd
2 Feb 24
ZEVRA THERAPEUTICS / R. LaDuane Clifton ownership change
8:11pm